Knowra Pharmaceutical formulation Pharmaceutical formulation Pharmaceutical formulation is the development of a medicine’s composition and physical form so its active ingredient can be manufactured, delivered, stored, and used.
Active pharmaceutical ingredient : The substance in a medicine responsible for its intended pharmacological effect. Its solubility, stability, and dose constrain the product’s composition and form.
Granulation : A process that forms powder particles into larger aggregates to improve handling and processing. It can make tablet blends flow and compress more consistently.
Oral drug delivery : Administration of medicines through the mouth for absorption in the gastrointestinal tract or local action. Oral products must withstand handling and often gastrointestinal conditions before releasing drug.
Immediate-release dosage : A dosage form designed to release its drug without deliberately extending or delaying release. It provides the baseline against which modified-release designs are compared.
Drug stability : A drug product’s ability to retain its identity, strength, quality, and purity over time under stated conditions. Formulation and packaging choices help limit degradation throughout the product’s shelf life.
Pharmaceutical excipient : An ingredient in a medicine other than its active pharmaceutical ingredient. Excipients enable manufacturing, protect the drug, and shape how a dose is released.
Tablet compression : The process of compacting powdered or granulated ingredients into tablets using a press. Compression determines tablet strength, porosity, and disintegration behavior.
Parenteral administration : Delivery of a medicine by a route that bypasses the gastrointestinal tract, such as injection or infusion. Parenteral formulations require suitable sterility, tolerability, and often precise concentration.
Generic drug : A medicine approved as equivalent to a reference product in relevant quality, safety, and effectiveness measures. Generic development must match critical product performance while permitting some formulation differences.
Bioavailability : The rate and extent to which an active drug reaches the systemic circulation or site of action. A formulation can change how much drug becomes available and how quickly.
Show all 28